Is Risperdal Approved for Autism?
No, Risperdal (risperidone) is not FDA-approved as a primary treatment for autism spectrum disorder (ASD). It is approved for irritability associated with ASD in children and adolescents aged 5-16, including aggression, self-injury, and tantrums.[1] This approval came in 2006 based on two 8-week trials showing reduced irritability scores on the Aberrant Behavior Checklist.[2]
How Is Risperdal Used Off-Label in Autism?
Risperdal treats behavioral symptoms in autism beyond the label, such as aggression, hyperactivity, and repetitive behaviors, often when other therapies fail. Pediatricians prescribe it off-label for broader age groups or symptoms, with studies showing short-term efficacy but high relapse rates after discontinuation.[3][4] Guidelines from the American Academy of Pediatrics recommend it only after behavioral interventions.
What Are the Common Side Effects?
Weight gain (up to 18 pounds in trials), increased prolactin levels (causing gynecomastia or menstrual issues), sedation, and extrapyramidal symptoms like tremors occur frequently.[1][2] Long-term risks include metabolic syndrome, diabetes, and tardive dyskinesia. Monitoring includes baseline prolactin, glucose, lipids, and BMI.[5]
Why Do Doctors Prescribe It Despite Risks?
Irritability affects up to 70% of autistic children, and risperdal reduces it by 50-70% in responders via dopamine D2 and serotonin 5-HT2A blockade.[3] It's preferred over haloperidol due to fewer movement disorders, but experts weigh benefits against metabolic risks, starting at low doses (0.25-0.5 mg/day).[4]
What Are the Alternatives?
- Other antipsychotics: Abilify (aripiprazole) is also FDA-approved for autistic irritability; less weight gain but similar prolactin risks.[2]
- Non-drug options: Applied behavior analysis (ABA), cognitive behavioral therapy, or SSRIs like fluoxetine for anxiety/repetitiveness.
- Other meds: Clonidine or guanfacine for hyperactivity; melatonin for sleep.[5]
Comparisons show risperdal edges out placebo but not always over alternatives in head-to-head trials.[3]
Who Makes Risperdal and What's the Generic Status?
Janssen (Johnson & Johnson) developed it; generic risperidone is available since 2008 after patent expiry.[6] No active patents block generics per DrugPatentWatch.com.[7]
Sources
[1]: FDA Label - Risperdal
[2]: McCracken et al., NEJM 2002
[3]: Marcus et al., J Am Acad Child Adolesc Psychiatry 2009
[4]: AAP Autism Guidelines 2019
[5]: NICE Guidelines on Autism
[6]: FDA Orange Book
[7]: DrugPatentWatch.com - Risperidone